T1DM Modeling Service

T1DM Modeling Service

Type 1 diabetes mellitus (T1DM) results from the autoimmune destruction of β-cells of the endocrine pancreas. Animal models can be used as suitable research tools for diabetes. Ace Therapeutics can provide modeling services of T1DM to accelerate customer research progress.

Overview of T1DM

Type 1 diabetes mellitus (T1DM) accounts for about 10% of all diabetic patients, also known as insulin dependent diabetes mellitus or juvenile diabetes, is an autoimmune disease that occurs mostly in children and adolescents. The β-cells in patients have been damaged, clinically manifested as insulin secretion disorder, increased blood sugar and ketosis tendency.

Fig 2. Immunologic History of Type 1 DiabetesImmunologic History of Type 1 Diabetes (Jeffrey, A. B.; et al. Nature. 2016)

T1DM Models

The pathogenesis of diabetes is complex and multifactorial. As an important research tool, experimental models of diabetes play an important role in the study of mechanisms, drug screening, and preclinical drug testing.

  • Mouse Models
    The available models of T1DM can be divided into spontaneously autoimmune, chemically induced, virus induced and genetically induced.
  • Spontaneously Models Nonobese diabetic (NOD) mouse, BioBreeding Diabetes-Prone (BB) rat and LEW-1AR1 / -iddm rat are the most widely studied models of T1DM.
    Chemically Induced The chemical compounds alloxan and streptozotocin (STZ) are commonly used to induce diabetes and destroy β-cells in animal models. The chemically induced destruction of β-cells leads to decreased insulin production, hyperglycemia and weight loss in the experimental animal.
    Genetically Induced The most commonly used genetically induced T1DM model is the so-called AKITA mouse (originally C57BL/6NSIc mouse). The development of diabetes in AKITA mice is caused by a spontaneous point mutation in the Ins2 gene, which is responsible for the correct composition of insulin in the endoplasmic reticulum.
    Virally Induced Among the most commonly used are coxsackie virus, lymphocytic choriomeningitis virus, encephalomyocarditis virus. Examples of virus-induced animals include NOD mice infected with coxsackie B4 that developed T1DM within two weeks.
  • Non-rodent Models
    In addition to the extensively studied rodent models of T1DM, several large animal models have been developed. In large animal models, spontaneous diabetes is relatively rare and unpredictable in onset, and thus, induced models of T1DM are required. The most common method of inducing insulin dependence in large models is either by pancreatectomy or STZ.

Our Services

Various animal models of disease are used to understand the pathogenesis and etiology of T1DM. Ace Therapeutics providing modeling service which can be customized by customer needs. Our services include but not limited to the followings.

Fig 3. Types of Diabetes Model

Types of Diabetes Models

  • Culture Cell Models
  • Non-human Primate Models
  • Mouse, Rat, Rabbit, Guinea Pig Models
  • Other Animal Model (Zebrafish, Drosophila, C. elegans, et al.)

Fig 4. Genetically Modified Model

Genetically Modified Diabetes Models

  • Knock-out (Large Deletion)
  • Knock-in (Point Mutation, Large Insertion)

Features of Our Services

Highly CustomizableHighly Customizable

One-stop ServicesOne-stop Services

High QualitysHigh Quality

Professional TeamProfessional Team

Ace Therapeutics offers cost-effect and high-quality research services for our clients worldwide. In addition, we offer a variety of mouse models and cell lines for diabetes research. Our assays are developed and processed with the highest standard and the results are delivered on time without compromising quality. Please feel free to contact us.

All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Related Services
Related Products
logo

Ace Therapeutics has a team of wellknown experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.

Quick Links
Contact Info
Copyright © Ace Therapeutics. All Rights Reserved.
Top